Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago region, 2007 to 2010

Ritu Banerjee, Ari Robicsek, Michael A. Kuskowski, Stephen Porter, Brian D Johnston, Evgeni Sokurenko, Veronika Tchesnokova, Lance B. Price, James R Johnson

Research output: Contribution to journalArticlepeer-review

103 Scopus citations

Abstract

We assessed Escherichia coli ST131 and its H30 and H30-Rx subclones for virulence genes, antimicrobial resistance, and extended-spectrum beta-lactamase (ESBL) type. Although both subclones were associated with ESBL production, H30-Rx isolates had higher resistance scores and were associated specifically with CTX-M-15. Three virulence genes (iha, sat, and iutA) were more prevalent among H30 than non-H30 ST131 isolates. Thus, the H30 and H30-Rx subclones are more antimicrobial resistant and have virulence profiles that are distinct from those of non-H30 ST131 isolates.

Original languageEnglish (US)
Pages (from-to)6385-6388
Number of pages4
JournalAntimicrobial agents and chemotherapy
Volume57
Issue number12
DOIs
StatePublished - Dec 2013

Fingerprint

Dive into the research topics of 'Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago region, 2007 to 2010'. Together they form a unique fingerprint.

Cite this